Research is uncovering ways in which sex as a biological variable affects health. The social environment’s effect on our biology also is increasingly acknowledged, along with data indicating that these effects vary by gender. Thus, both biological sex and gendered experience can play a role in the physiological mechanisms of disease. A newly published paper in the journal Cell asserts that despite the challenges in navigating the paradigm shift required to study the effects of sex and gender as well as the biological and social determinants of health, the future of science is to study how these factors intersect.
News
Information about the Supreme Court Decision Dobbs vs Jackson’s Women’s Health Organization
These are articles written and shared by our Yale Law professors Linda Greenhouse, Reva Siegel and Priscilla Smith:
Requiem for the Supreme Court, New York Times Opinion by Linda Greenhouse
The Trump court limited women’s rights using 19th-century standards, The Washington Post Perspective by Riva Siegel
What if Roe fell?, Center for Reproductive Rights
Latest News
Valentina Greco, PhD, Carolyn Walch Slayman Professor of Genetics, was named one of “50 Scientists that Inspire” from Cell Press.
- January 24, 2025Source: MedScape
An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study of any blood-based CRC screening test.
- January 14, 2025Source: The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss, and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy
... - January 14, 2025Source: YouTube/The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss, and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy
... - January 06, 2025
Two Yale School of Medicine faculty and one staff member won the 2024 Rosemarie L. Fisher, MD, Excellence in Graduate Medical Education Award: Katja Goldflam, MD, associate program director for the Emergency Medicine Residency; Laura Morrison, MD, program director of the Hospice and Palliative Medicine Fellowship; and Sadhvi Khanna, MBA, MPH, program coordinator of the Anesthesiology Residency Program.
- January 06, 2025
The Yale Department of Internal Medicine is pleased to highlight the following professors of medicine.
- December 31, 2024
Yale Cancer Center and Smilow Cancer Hospital people who have been honored
- December 31, 2024
A listing of recent publications by Yale Cancer Center researchers and clinicians in the first quarter of 2024
- December 24, 2024Source: Parade
"Though a lot of people attribute small amounts of blood in their stool to common benign causes such as hemorrhoids, it is essential to always get this evaluated to ensure there is not something more serious such as a cancer," Dr. Michelle Hughes, MD, gastroenterologist and medical chief of quality and safety, digestive health, at Yale New Haven Health, explained. "This is true no matter your age as early-onset colon cancer rates are on the rise and we are seeing patients in their 20s and 30s presenting with bleeding as the first sign of a cancer."
- December 20, 2024
After more than 24 years of leading The Community Foundation for Greater New Haven, President and CEO Will Ginsberg announced his retirement effective November 1, 2024. To mark this milestone, we recently spoke with Ginsberg about The Foundation’s growth and impact as well as its relationship with Women’s Health Research at Yale.